Hansen invests in temperature monitoring tech
This article was originally published in Clinica
Executive Summary
Hansen Medical has gained exclusive rights to temperature measurement technology, developed by Advanced Cardiac Therapeutics (ACT), for certain robotic applications. In exchange, Hansen made an undisclosed equity investment in the Laguna Beach, California-based firm. According to Hansen (Mountain View, California), existing manual technology used to control catheters in electrophysiology procedures provides only limited precision and stability, and cannot accurately sense tissue temperature and its potential effect on lesion quality. ACT’s microwave radiometry system, when integrated into the catheters used with Hansen’s Sensei robotic catheter system, could provide electrophysiologists with real-time feedback about effective energy delivery in catheters. Financial terms of the deal were not disclosed.